首页> 外文期刊>Nutrition Journal >Relationships of low serum vitamin D3 with anthropometry and markers of the metabolic syndrome and diabetes in overweight and obesity
【24h】

Relationships of low serum vitamin D3 with anthropometry and markers of the metabolic syndrome and diabetes in overweight and obesity

机译:低血清维生素D 3 与人体测量学以及超重和肥胖中代谢综合征和糖尿病标志物的关系

获取原文
           

摘要

Low serum 25 hydroxyvitamin D3 (vitamin D3) is known to perturb cellular function in many tissues, including the endocrine pancreas, which are involved in obesity and type II diabetes mellitus (TIIDM). Vitamin D3 insufficiency has been linked to obesity, whether obesity is assessed by body mass index (BMI) or waist circumference (waist). Central obesity, using waist as the surrogate, is associated with the metabolic syndrome (MetSyn), insulin resistance, TIIDM and atherosclerotic cardiovascular disease (CVD). We tested how vitamin D3 was related to measures of fat mass, MetSyn markers, haemoglobin A1c (HbA1c) and MetSyn in a cross-sectional sample of 250 overweight and obese adults of different ethnicities. There were modest inverse associations of vitamin D3 with body weight (weight) (r = -0.21, p = 0.0009), BMI (r = -0.18, p = 0.005), waist (r = -0.14, p = 0.03), [but not body fat % (r = -0.08, p = 0.24)], and HbA1c (r = -0.16, p = 0.01). Multivariable regression carried out separately for BMI and waist showed a decrease of 0.74 nmol/L (p = 0.002) in vitamin D3 per 1 kg/m2 increase in BMI and a decrease of 0.29 nmol/L (p = 0.01) per 1 cm increase in waist, with each explaining approximately 3% of the variation in vitamin D3 over and above gender, age, ethnicity and season. The similar relationships of BMI and waist with vitamin D3 may have been due to associations between BMI and waist, or coincidental, where different mechanisms relating hypovitaminosis D3 to obesity occur concurrently. Previously reviewed mechanisms include that 1) low vitamin D3, may impair insulin action, glucose metabolism and various other metabolic processes in adipose and lean tissue 2) fat soluble-vitamin D3 is sequestered in the large adipose compartment, and low in serum, 3) obese people may be sensitive about their body shape, minimising their skin exposure to view and sunlight (not tested). We showed evidence for the first theory but no evidence to support the second. In the current study, serum vitamin D3 was inversely related to weight, BMI and markers of TIIDM (large waist, raised HbA1c) but not to adipose mass nor to MetSyn per se.
机译:低血清25羟基维生素D3(维生素D3)会扰乱许多组织的细胞功能,包括与肥胖和II型糖尿病(TIIDM)有关的内分泌胰腺。维生素D3功能不全与肥胖有关,无论肥胖是通过体重指数(BMI)还是腰围(腰围)评估的。以腰部为替代的中心型肥胖与代谢综合征(MetSyn),胰岛素抵抗,TIIDM和动脉粥样硬化性心血管疾病(CVD)有关。我们在250名不同种族的超重和肥胖成年人的横断面样本中测试了维生素D3与脂肪量,MetSyn标记,血红蛋白A1c(HbA1c)和MetSyn的量度如何相关。维生素D3与体重(重量)(r = -0.21,p = 0.0009),BMI(r = -0.18,p = 0.005),腰围(r = -0.14,p = 0.03)有适度的逆相关性,[但不是身体脂肪%(r = -0.08,p = 0.24)]和HbA1c(r = -0.16,p = 0.01)。分别针对BMI和腰部进行的多变量回归显示,每增加1 kg / m2,维生素D3下降0.74 nmol / L(p = 0.002),而每增加1 cm则维生素D3下降0.29 nmol / L(p = 0.01)在腰部,每个人解释了大约3%的维生素D3在性别,年龄,种族和季节之外的变化。 BMI和腰部与维生素D3的相似关系可能是由于BMI与腰部或巧合之间的关联所致,在这种情况下,维生素D3缺乏症与肥胖症的不同机制同时发生。先前审查过的机制包括:1)低维生素D3可能会损害脂肪和瘦肉组织中的胰岛素作用,葡萄糖代谢和其他各种代谢过程2)脂溶性维生素D3被隔离在大的脂肪区室中,血清含量低,3)肥胖的人可能对自己的身体形状敏感,从而使他们的皮肤暴露于视野和阳光下的可能性降到最低(未经测试)。我们为第一种理论提供了证据,但没有证据支持第二种理论。在当前的研究中,血清维生素D3与体重,BMI和TIIDM的指标(大腰,HbA1c升高)成反比,但与脂肪量或MetSyn本身无关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号